All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

3,685

Reset

3,685 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • NEU-411Phase 21 trial

    Neuron23 Inc. · Parkinson Disease, Parkinson, Idiopathic Parkinson Disease

  • NG101mPhase 21 trial

    NeuGATE Theranostics · Glioblastoma Multiforme

  • NGGT001Phase 21 trial

    NGGT (Suzhou) Biotechnology Co., Ltd. · Bietti Crystalline Corneoretinal Dystrophy

  • NGI226Phase 21 trial

    Novartis · Achilles Tendinopathy

  • NGM120Phase 21 trial

    NGM Biopharmaceuticals, Inc · Colorectal Cancer, CRC (Colorectal Cancer), Cancer Cachexia

  • NH102Phase 21 trial

    Jiangsu Nhwa Pharmaceutical Co., Ltd. · Major Depressive Disorder (MDD)

  • NHS7108Phase 21 trial

    Aimmune Nestlé Health Science US R&D, LLC · Exocrine Pancreatic Insufficiency (EPI), Cystic Fibrosis (CF), Pancreatic Enzyme Abnormality

  • NHT102Phase 21 trial

    Nob Hill Therapeutics, Inc. · NSCLC (Advanced Non-small Cell Lung Cancer)

  • NIDO-361Phase 21 trial

    Nido Biosciences, Inc. · Spinal and Bulbar Muscular Atrophy, Kennedy's Disease

  • NimacimabPhase 21 trial

    Skye Bioscience, Inc. · Obesity

  • NIO752Phase 21 trial

    Novartis · Progressive Supranuclear Palsy, Corticobasal Degeneration, Frontotemporal Lobar Degeneration

  • NKT2152Phase 21 trial

    Roche (Genentech) · Advanced Liver Cancers

  • NKTR-255Phase 21 trial

    EMD Serono Research & Development Institute, Inc. · Locally Advanced or Metastatic Urothelial Carcinoma

  • NLS-133Phase 21 trial

    Next Life Sciences · Male Contraception, Semen Volume, Sperm Motility

  • NN2802Phase 21 trial

    Novelty Nobility, Inc. · Healhty, Chronic Spontaneous Urticaria (CSU)

  • NNC0662-3168Test product-APhase 21 trial

    Novo Nordisk · Overweight, Obesity, Type 2 Diabetes Mellitus

  • NOC-110taplucainiumPhase 21 trial

    Nocion Therapeutics · Refractory or Unexplained Chronic Cough

  • NOE-115Phase 21 trial

    Noema Pharma AG · Menopause Syndrome, Menopause, Hot Flashes

  • NoNO-42Phase 21 trial

    NoNO Inc. · Acute Ischemic Stroke

  • NORA520Phase 21 trial

    TWi Biotechnology, Inc. · Depression, Postpartum, Postpartum Depression, Post-partum Depression

  • NP137Phase 21 trial

    NETRIS Pharma · Endometrial Carcinoma, Cervix Carcinoma

  • NPT 2042Phase 21 trial

    NeuroPro Therapeutics, Inc. · Epilepsy, Generalized, Epilepsy, Absence

  • NRC-2694-APhase 21 trial

    NATCO Pharma Ltd. · Carcinoma, Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma

  • NS-050NCNP-03Phase 21 trial

    NS Pharma, Inc. · Duchenne Muscular Dystrophy

  • NS-136Phase 21 trial

    NeuShen Therapeutics · Schizophrenia(Acute)

  • NS-229Phase 21 trial

    NS Pharma, Inc. · Eosinophilic Granulomatosis With Polyangiitis, Churg-Strauss Syndrome

  • NS101Phase 21 trial

    Neuracle Science Co., LTD. · Seneorineural Deafness, Sudden Sensorineural Hearing Loss

  • NSC001Phase 21 trial

    NSC-Therapeutics · Alzheimer Disease

  • NSI-8226Phase 21 trial

    Uniquity One (UNI) · Asthma

  • NST-1024Phase 21 trial

    NorthSea Therapeutics B.V. · High Triglycerides

  • NST-6179Phase 21 trial

    NorthSea Therapeutics B.V. · Intestinal Failure Associated Liver Disease

  • NTB003Phase 21 trial

    Nanjing Chia-tai Tianqing Pharmaceutical · Thyroid Eye Disease

  • NTRX-07MDA7Phase 21 trial

    NeuroTherapia, Inc. · Alzheimer Disease, Mild Cognitive Impairment

  • NTS-521Phase 21 trial

    NeuroTrauma Sciences, LLC · Acute Ischemic Stroke

  • NTS071Phase 21 trial

    Nutshell Therapeutics (Shanghai) Co., LTD. · Advanced Solid Tumors

  • NTX-1472Phase 21 trial

    Newleos Therapeutics, Inc. · Social Anxiety Disorder (SAD)

  • NUV-1511Phase 21 trial

    Nuvation Bio Inc. · Advanced Solid Tumor, HER2-negative Breast Cancer, Metastatic Castration-resistant Prostate Cancer (mCRPC)

  • NV-5138SPN820Phase 21 trial

    Navitor Pharmaceuticals, Inc. · Treatment Resistant Depression

  • NV01-A02Phase 21 trial

    Neuroventi Inc. · Autism Spectrum Disorder (ASD

  • NVG-2089Phase 21 trial

    Nuvig Therapeutics, Inc. · Immune Thrombocytopenia (ITP)

  • NX210cPhase 21 trial

    Axoltis Pharma · Amyotrophic Lateral Sclerosis

  • NXC736Phase 21 trial

    NEXTGEN Bioscience · Alopecia Areata

  • NYX-458Phase 21 trial

    Aptinyx · Mild Cognitive Impairment, Mild Dementia, Parkinson Disease

  • OATD-01Phase 21 trial

    Molecure S.A. · Pulmonary Sarcoidosis

  • OBI-902Phase 21 trial

    OBI Pharma, Inc · Advanced Solid Tumor

  • OBI-992Phase 21 trial

    OBI Pharma, Inc · Advanced Solid Tumor

  • OBX-115Phase 21 trial

    Obsidian Therapeutics, Inc. · Tumor Skin, Metastatic Melanoma, Melanoma

  • OCU400Phase 21 trial

    Ocugen · Retinitis Pigmentosa, Leber Congenital Amaurosis

  • OD-07656Phase 21 trial

    Odyssey Therapeutics, Inc. · Ulcerative Colitis (UC), UC - Ulcerative Colitis

  • ODM-216Phase 21 trial

    Orion Corporation, Orion Pharma · Advanced Solid Tumors Cancer

NewerPage 63 of 74Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.